Trial Profile
A retrospective study to evaluate efficacy and safety of Anakinra for treatment of acute gouty arthritis in a medically complex in-patient cohort
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Jan 2017
Price :
$35
*
At a glance
- Drugs Anakinra (Primary)
- Indications Gout; Gouty arthritis
- Focus Adverse reactions; Therapeutic Use
- 24 Jan 2017 New trial record